FDA Suspends Ixchiq Vaccine After 1.5 Years of Safety Data Showed Serious Risk
Facts Matter · The Epoch Times
August 27, 20258m 17s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On Aug. 25, the FDA informed the public that the agency officially suspended its approval for Valneva’s Ixchiq vaccine.
Ixchiq is a vaccine for Chikungunya, a mosquito-borne disease. The vaccine was initially approved to be administered in the United States in November 2023, under the FDA’s fast-tracked accelerated approval pathway.
Let’s go through what the data showed, as well as why the FDA decided this move to stop the vaccine was necessary.